Sunmax Biotechnology
4728.TWO
11.88 USD
-0.42
-3.41%
s
Overview
Last close
11.88 usd
Market cap
647.15M usd
52 week high
16.11 usd
52 week low
11.62 usd
Target price
N/A usd
Valuation
P/E
26.0081
Forward P/E
30.7692
Price/Sales
9.6026
Price/Book Value
14.7297
Enterprise Value
625.53M usd
EV/Revenue
9.2906
EV/EBITDA
16.4829
Key financials
Revenue TTM
67.33M usd
Gross Profit TTM
53.24M usd
EBITDA TTM
36.04M usd
Earnings per Share
0.46 usd
Dividend
0.37 usd
Total assets
62.95M usd
Net debt
N/A usd
About
Sunmax Biotechnology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally. It offers collagen dermal filler sets, such as Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO injectable collagen gel with lidocaine. The company was founded in 2001 and is based in Tainan City, Taiwan.
- Symbol4728.TWO
- ExchangeTWO
- IsinTW0004728001
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CEO
- HeadquarterTainan City
- Web sitehttps://www.sunmaxbiotech.com
